No Data
No Data
TG Therapeutics to Participate in the Evercore HealthCONx Conference
JP Morgan Maintains Overweight on TG Therapeutics, Raises Price Target to $43
TG Therapeutics Analyst Ratings
J.P. Morgan Maintains TG Therapeutics(TGTX.US) With Buy Rating, Raises Target Price to $43
Express News | TG Therapeutics Inc : JP Morgan Raises Target Price to $43 From $30
A Closer Look at TG Therapeutics's Options Market Dynamics